ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 0151

Usefulness of Ultrasound and (FDG) PET/CT to Detect Cranial and Extracranial Artery Involvement in Patients with Suspected Large Vessel Vasculitis

Juan Molina1, Isabel Castrejón2, Javier Rivera2, Julia Martínez Barrio2, Juan Carlos Nieto2, Katerine López2, Fernando Montero2, Laura Trives Folguera2, Carlos González3 and Jose Maria Alvaro-Gracia2, 1Hospital General Universitario Gregorio Maran, Madrid, Spain, 2Hospital General Universitario Gregorio Marañón, Madrid, Spain, 3CEIMI, Hospital General Universitario Gregorio Marañón, Madrid, Spain

Meeting: ACR Convergence 2021

Keywords: giant cell arteritis, Imaging, Takayasu.s arteritis, Ultrasound, Vasculitis

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Imaging of Rheumatic Diseases Poster (0149–0182)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Ultrasound (US) is recommended as the first imaging modality to assess patients presenting with predominantly cranial symptoms of giant cell arteritis (GCA). However, its value in assessing extra-cranial involvement remains unclear, being the 8F-fluorodeoxyglucose (FDG) PET/CT the ancillary study recommended. We aim to compare US versus FDG PET/CT to detect cranial and extra-cranial artery involvement in patients with suspected large vessel vasculitis (LVV).

Methods: Retrospective observational study including patients referred to a GCA fast track pathway (FTP) over a 2-years period. All patients underwent US exam of temporal (TA) and large vessel (LV) (carotid, subclavian and axillary) arteries within 24 hours of referral per protocol. Positive US findings were defined as a halo and/or compression sign in TA and a halo and/or intima media thickness >1mm in LV arteries. FDG PET/CT was performed per clinician criteria and was defined as positive if an artery FDG uptake was higher than liver uptake. The qualitative FDG uptake in the aorta, its aortic branches (carotid, axillary and subclavian), iliac and cranial arteries was also registered. All US exams were made before the FDG PET/CT evaluation. The external criterion for US and FDG PET/CT comparison was LVV clinical confirmation after 6 months follow-up.

Results: A total of 113 patients were included, 74.3% female with mean age 74 (11) years. After 6 months of follow-up, 37 (32.7%) patients had LVV clinical confirmation (34 GCA and 3 Takayasu). Only 3 (3.9%) patients without LVV versus 32 (86.5%) with LVV had positive US findings (Table 1). Among patients with LVV, 24 (64.9%) had TA involvement and 16 (43.2%) had extra-cranial LVV according to US examination (37.8% axillary, 29.7% subclavian and 32.4% carotid artery involvement). We found a mixed pattern with involvement of both TA and LV arteries in 8 (21.6%) patients. Overall, sensitivity and specificity of US for LVV was 86.5% and 96.1%, respectively, and for exclusively LV involvement was 94.1% and 80.2 %, respectively. A total of 28 patients underwent a FDG-PET/CT, of whom 12 (42.9%) showed positive findings. Taking FDG-PET/CT as the reference, US showed positive extracranial findings in 10 (83.3%) of those 12 patients and was able to detect 2 (12.5%) additional cases of large vessel involvement with negative FDG-PET/CT examination (Table 2). On the other hand, FDG-PET/CT showed LV artery involvement in 2 patients with negative US findings (1 patient with isolated aortitis and 1 patient with aorta and iliac artery involvement) (Table 3). FDG-PET/CT showed cranial arteries uptake in none of patients.

Conclusion: US is comparable to FDG-PET/CT for LVV diagnosis. Although presence of US extra-cranial artery inflammation is consistent with FDG-PET/CT examination, a negative US scan does not rule out extracranial involvement. FDG-PET/CT is of limited value for assessing cranial arteries. Thus, US may be used as the first line investigation not only in suspected cranial, but also extracranial LVV.

Table 1. Clinical, laboratory and imaging findings of patients included in the fast track pathway with and without LVV. LVV: large vessel vasculitis; PMR: polymyalgia rheumatica; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; US: ultrasound; SD: standard deviation

Table 2. Ultrasound findings of patients included in the fast-track pathway taking FDG-PET/CT as the reference for large vessel vasculitis. LVV: large vessel vasculitis; US: ultrasound

Table 3. Comparison between US and PET/CT findings in patients with PET/TC proven LVV. TA: temporal artery; CA: carotid artery; AA: axillary artery; SA: subclavian artery, IA: iliac artery


Disclosures: J. Molina, None; I. Castrejón, None; J. Rivera, None; J. Martínez Barrio, None; J. Nieto, None; K. López, None; F. Montero, None; L. Trives Folguera, None; C. González, None; J. Alvaro-Gracia, None.

To cite this abstract in AMA style:

Molina J, Castrejón I, Rivera J, Martínez Barrio J, Nieto J, López K, Montero F, Trives Folguera L, González C, Alvaro-Gracia J. Usefulness of Ultrasound and (FDG) PET/CT to Detect Cranial and Extracranial Artery Involvement in Patients with Suspected Large Vessel Vasculitis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/usefulness-of-ultrasound-and-fdg-pet-ct-to-detect-cranial-and-extracranial-artery-involvement-in-patients-with-suspected-large-vessel-vasculitis/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/usefulness-of-ultrasound-and-fdg-pet-ct-to-detect-cranial-and-extracranial-artery-involvement-in-patients-with-suspected-large-vessel-vasculitis/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology